The Four-type HPV Vaccine Gardasil(R) Demonstrates Real Life Benefits

Results from an observational study in Australia establish that after only one year of a comprehensive vaccination programme with the four-type (6,11,16,18) human papillomavirus (HPV) Gardasil® major benefits are already being seen. The study results will be presented at the 25th International Papillomavirus Conference (IPV) in Malmö, Sweden.

More: continued here

Filed under: Cervical Cancer on May 12th, 2009